FDA opening hearing on arthritis drug safety

Al Smith Published:

FDA opening hearing on arthritis drug safety WASHINGTON (AP) With Vioxx off the market because of links to heart problems and concerns growing about the related drugs Celebrex and Bextra, a pair of Food and Drug Administration advisory committees are as